1-28742919-A-G
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_016258.3(YTHDF2):c.649A>G(p.Thr217Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000812 in 1,614,090 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T217S) has been classified as Likely benign.
Frequency
Consequence
NM_016258.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
YTHDF2 | NM_016258.3 | c.649A>G | p.Thr217Ala | missense_variant | Exon 4 of 5 | ENST00000373812.8 | NP_057342.2 | |
YTHDF2 | NM_001173128.2 | c.649A>G | p.Thr217Ala | missense_variant | Exon 5 of 6 | NP_001166599.1 | ||
YTHDF2 | NM_001172828.2 | c.499A>G | p.Thr167Ala | missense_variant | Exon 3 of 4 | NP_001166299.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000723 AC: 11AN: 152196Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000962 AC: 24AN: 249566Hom.: 0 AF XY: 0.000118 AC XY: 16AN XY: 135398
GnomAD4 exome AF: 0.0000821 AC: 120AN: 1461894Hom.: 0 Cov.: 32 AF XY: 0.0000784 AC XY: 57AN XY: 727248
GnomAD4 genome AF: 0.0000723 AC: 11AN: 152196Hom.: 0 Cov.: 32 AF XY: 0.0000538 AC XY: 4AN XY: 74364
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.649A>G (p.T217A) alteration is located in exon 4 (coding exon 4) of the YTHDF2 gene. This alteration results from a A to G substitution at nucleotide position 649, causing the threonine (T) at amino acid position 217 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at